Kidney tumours: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (385 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Kidney tumours''' - includes '''malignant kidney tumours''' and '''benign kidney tumours'''. Medical renal diseases are dealt with in the [[medical renal diseases]] article. | [[Image:Renal oncocytoma.jpg|thumb|250px|A kidney tumour ([[renal oncocytoma]]). (WC/Emmanuelm)]] | ||
'''[[Kidney]] tumours''' - includes '''malignant kidney tumours''' ('''kidney cancer''') and '''benign kidney tumours'''. Medical renal diseases are dealt with in the [[medical renal diseases]] article. | |||
Pediatric kidney tumours are dealt with in the ''[[pediatric kidney tumours]]'' article. | |||
=Renal specimens= | |||
*[[Renal biopsy]] - usually for [[renal oncocytoma]] vs. renal cell carcinoma (RCC) ''or'' medical diseases - see ''[[medical kidney]]''. | |||
*[[Partial nephrectomy]]. | |||
*[[Nephrectomy]]. | |||
*[[Nephroureterectomy]] (includes [[ureter]]) - done for [[urothelial cell carcinoma]] (UCC) of the renal pelvis and ureteric UCC. | |||
*[[Radical nephrectomy]] - includes Gerota's fascia. | |||
**May include the [[adrenal gland]].<ref name=Ref_WMSP|288>{{Ref WMSP|288}}</ref> | |||
In excisions done for tumours, a comment should be made about kidney distant from the tumour. People with less renal mass, i.e. less kidney, are predisposed to focal segmental glomerulosclerosis (FSGS). | |||
== | ==Anatomy== | ||
Layers (superficial to deep): | |||
#Renal fascia (Gerota's fascia). | |||
#Perinephric fat. | |||
#Renal capsule. | |||
#Renal parenchyma (cortex). | |||
=== | ===Sign out=== | ||
====Missed renal biopsy==== | |||
{{Main|Missed renal biopsy}} | |||
= | =Tabular comparison (selected tumours)= | ||
Selected common tumours of the kidney:<ref name=Ref_GUP281>{{Ref GUP|281-304}}</ref><ref name=pmid19494850>{{Cite journal | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | title = Uncommon and recently described renal carcinomas. | journal = Mod Pathol | volume = 22 Suppl 2 | issue = | pages = S2-S23 | month = Jun | year = 2009 | doi = 10.1038/modpathol.2009.70 | PMID = 19494850 }}</ref> | |||
= | |||
{| class="wikitable" | {| class="wikitable" | ||
| | | | ||
| '''Clear cell RCC''' | |||
| '''Papillary RCC<br>type 1''' | |||
| '''Papillary RCC<br>type 2''' | |||
| '''Chromophobe RCC<br>classic variant''' | |||
| '''Chromophobe RCC<br>eosinophilic variant''' | |||
| '''Oncocytoma''' | |||
|- | |- | ||
|Gross | |Gross | ||
| Golden yellow, solid | |||
| friable | |||
| friable | |||
| light brown | |||
| light brown | |||
| mahogany/brown, +/-central scar | |||
|- | |- | ||
|Architecture | |Architecture | ||
| nests, sheets | |||
| papillary, simple | |||
| papillary,<br>pseudostratified | |||
| nests, sheets | |||
| nests, sheets | |||
| nests, sheets | |||
|- | |- | ||
|Nuclear atypia | |Nuclear atypia | ||
| low-high<br>typically medium-high | |||
| low-medium | |||
| medium-high | |||
| low-high, "raisinoid" <br>nuc. membrane | |||
| low-high, "raisinoid" <br>nuc. membrane | |||
| low-medium, round nuclei | |||
|- | |- | ||
|Cytoplasm | |Cytoplasm | ||
| clear | |||
| eosinophilic | |||
| eosinophilic | |||
| cobwebs/clear | |||
| eosinophilic/cobwebs | |||
| eosinophilic/<br>granular & abundant | |||
|- | |- | ||
|Other | |Other | ||
| delicate vessels,<br>[[necrosis]] common | |||
| histiocytes<br> in fibrovascular cores, >0.5 cm | |||
| histiocytes<br> in fibrovascular cores, >0.5 cm | |||
| perinuclear clearing, thick vessels | |||
| perinuclear clearing, thick vessels | |||
| in loose fibrous/hyaline stroma | |||
|- | |- | ||
|IHC | | |IHC | ||
| [[CK7]]-, EMA+ | |||
| AMACR+, EMA+, CK7+ | |||
| AMACR+, E-cadherin+, CK7- | |||
| CD117+, CK7+ (membrane) | |||
| CD117+, CK7+ (membrane) | |||
| Vimentin-, EMA+ | |||
|- | |- | ||
|Main DDx | |Main DDx | ||
| chromophobe<br>classic variant | |||
| PaRCC type 2, mets | |||
| PaRCC type 1, mets | |||
| clear cell RCC | |||
| oncocytoma | |||
| chromophobe<br>eosinophilic variant | |||
|- | |- | ||
|Key features | |Key features | ||
| clear cells, vascular | |||
| papillae, histiocytes<br>simple epithelium | |||
| papillae, histiocytes,<br>stratified | |||
| perinuc. clearing,<br>wispy cytoplasm | |||
| perinuc. clearing,<br>wispy eosinophilic<br>cytoplasm | |||
| eosinophilic, granular cytoplasm | |||
|- | |||
|Image(s) | |||
| [[Image:Renal_clear_cell_ca_%281%29_Nephrectomy.jpg|thumb|150px| CCRCC (WC)]] | |||
| [[Image:Papillary_renal_cell_carcinoma_intermed_mag.jpg|thumb|150px| PaRCC - intermed. (WC)]], [[Image:Papillary_renal_cell_carcinoma_very_high_mag.jpg | thumb|150px| PaRCC - high (WC)]] | |||
| | |||
| | |||
| [[Image:Oncocytic_chromophobe_rcc_high_mag.jpg|thumb|150px| ChRCC (WC)]] | |||
| [[Image:Renal_oncocytoma2.jpg|thumb|150px| Oncocytoma (WC)]] | |||
|} | |} | ||
Notes: | Notes: | ||
*Cell shape: all have epithelioid morphology. | *Cell shape: all have epithelioid morphology. | ||
== | ===Tabular comparison of oncocytoma and chromophobe RCC=== | ||
Histomorphologic features useful to distinguish chromophobe RCC (eosinophilic variant) and oncocytoma:<ref name=pmid9844591>{{Cite journal | last1 = Tickoo | first1 = SK. | last2 = Amin | first2 = MB. | title = Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. | journal = Am J Clin Pathol | volume = 110 | issue = 6 | pages = 782-7 | month = Dec | year = 1998 | doi = | PMID = 9844591 }}</ref> | |||
{| class="wikitable sortable" | |||
! Morphologic feature | |||
! [[ChRCC]] (eosinophilic<br> variant) | |||
! [[Renal oncocytoma]] | |||
|- | |||
| Nuclear morphology | |||
| "raisinoid"/wrinkled appearance | |||
| round with small nucleolus, <br>usu. little size variation | |||
|- | |||
| Multinucleation | |||
| common - binucleation | |||
| uncommon | |||
|- | |||
| Chromatin | |||
| coarse | |||
| fine | |||
|- | |||
| Architecture | |||
| solid, crowded nests | |||
| spaced nests / <br>archipelago-like, solid | |||
|- | |||
| Cytoplasm | |||
| perinuclear halo, may be focal | |||
| no perinuclear halo | |||
|- | |||
| Degenerative foci<br>(focal atypia & pleomorphism) | |||
| absent | |||
| present in ~20% of cases | |||
|- | |||
| Image | |||
| [[Image:Oncocytic_chromophobe_rcc_high_mag.jpg |thumb|150px|ChRCC (WC/Nephron)]] | |||
| [[Image:Renal_oncocytoma2.jpg |thumb|150px|Oncocytoma (WC/Nephron)]] | |||
|} | |||
== | ===Common DDx=== | ||
====Spindle cell tumours==== | |||
* | Malignant spindle cell tumours of the kidney: | ||
* | *[[Renal cell carcinoma with sarcomatoid differentiation]]. | ||
*[[Renal mucinous tubular and spindle cell carcinoma]]. | |||
*[[Wilms tumour]]. | |||
*[[Renal cell carcinoma, unclassified]]. | |||
Benign spindle cell tumours of the kidney: | |||
*[[Angiomyolipoma]]. | |||
*[[Cystic nephroma]]. | |||
* | |||
* | |||
=== | ====Renal tumours with eosinophilic cytoplasm==== | ||
{{Main|Renal tumours with eosinophilic cytoplasm}} | |||
== | =WHO classification of renal neoplasia= | ||
=== | *Based on 2004 iteration - as per WMSP, slightly modified.<ref>{{Ref WMSP|291}}</ref> Online, the classification can [http://www.urosource.com/fileadmin/user_upload/european_urology/PIIS0302283805008316.pdf found here]. | ||
* | ===Renal cell tumours=== | ||
* | Common: | ||
* | *[[Clear cell renal cell carcinoma]]. | ||
*[[Papillary renal cell carcinoma]]. | |||
*[[Renal papillary adenoma|Papillary adenoma]]. | |||
*[[Chromophobe renal cell carcinoma]]. | |||
*[[Renal oncocytoma|Oncocytoma]]. | |||
Less common: | |||
*[[Multilocular clear cell renal cell carcinoma]]. | |||
* | *[[Carcinoma of the collecting ducts of Bellini]]. | ||
* | *[[Renal cell carcinoma, unclassified]]. | ||
* | *[[Renal medullary carcinoma]]. | ||
*[[Renal tumour with Xp11.2 translocation|Xp11 translocation carcinoma]]. | |||
*[[Mucinous tubular and spindle cell carcinoma]]. | |||
*Carcinoma associated with neuroblastoma. | |||
* | ===Metanephric tumours=== | ||
* | *[[Metanephric adenoma]]. | ||
*[[Metanephric stromal tumour]]. | |||
*[[Metanephric adenofibroma]]. | |||
=== | ===Nephroblastic tumours=== | ||
* | *Nephrogenic rests. | ||
* | *[[Nephroblastoma]]. | ||
===Mesenchymal tumours=== | |||
Childhood: | |||
*[[Clear cell sarcoma of the kidney]]. | |||
* | *[[Rhabdoid tumour]]. | ||
*[[Mesoblastic nephroma|Congenital mesoblastic nephroma]]. | |||
* | |||
Adults: | |||
* | *Unique to kidney: | ||
**[[Juxtaglomerular cell tumour]]. | |||
**[[Renomedullary interstitial cell tumour]]. | |||
Other: | |||
*[[Angiomyolipoma]]. | |||
*[[Epithelioid angiomyolipoma]]. | |||
*[[Leiomyosarcoma]]. | |||
*[[Angiosarcoma]]. | |||
*[[Pleomorphic undifferentiated sarcoma]]. | |||
*[[Hemangiopericytoma]]. | |||
*[[Solitary fibrous tumour]]. | |||
*[[Osteosarcoma]]. | |||
*[[Schwannoma]]. | |||
=== | ===Mixed mesenchymal and epithelial tumours=== | ||
*[[Cystic nephroma]]. | |||
*[[Mixed epithelial and stromal tumour]]. | |||
* | *[[Synovial sarcoma]]. | ||
* | |||
* | |||
===Others=== | |||
* | *[[Neuroendocrine tumours]]. | ||
* | *Hematologic tumours. | ||
* | *[[Germ cell tumour]]s. | ||
* | *[[Metastases]]. | ||
== | ==Vancouver modification of WHO classification== | ||
In 2012/2013, several additions were made:<ref name=pmid24025519>{{Cite journal | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | last3 = Eble | first3 = JN. | last4 = Egevad | first4 = L. | last5 = Epstein | first5 = JI. | last6 = Grignon | first6 = D. | last7 = Hes | first7 = O. | last8 = Moch | first8 = H. | last9 = Montironi | first9 = R. | title = The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. | journal = Am J Surg Pathol | volume = 37 | issue = 10 | pages = 1469-89 | month = Oct | year = 2013 | doi = 10.1097/PAS.0b013e318299f2d1 | PMID = 24025519 }}</ref> | |||
* | *[[Tubulocystic renal cell carcinoma]]. | ||
* | *[[Acquired cystic disease associated renal cell carcinoma]]. | ||
* | *[[Clear cell papillary renal cell carcinoma]] (clear cell tubulopapillary renal cell carcinoma). | ||
* | *[[Hereditary leiomyomatosis renal cell carcinoma syndrome associated renal cell carcinoma]]. | ||
*MiT family translocation renal cell carcinoma - includes: | |||
**[[t(6;11) renal cell carcinoma]]. | |||
"Emerging" entities (as per Vancouver) are: | |||
*[ | *[[Thyroid-like follicular renal cell carcinoma]]. | ||
*[[Succinate dehydrogenase-deficient renal cell carcinoma]]. | |||
*[[ALK translocation renal cell carcinoma]]. | |||
=== | ==Entities proposed after Vancouver== | ||
*Papillary | *[[Eosinophilic, solid and cystic renal cell carcinoma]] - part of 2022 WHO Classification. | ||
*[[Biphasic hyalinizing psammomatous renal cell carcinoma]]. | |||
*[[Papillary renal neoplasm with reverse polarity]]. | |||
*[[Low-grade oncocytic renal tumour]]. | |||
== | =Renal cell carcinoma= | ||
==Overview== | |||
===General=== | ===General=== | ||
* | *Relatively common form of cancer. | ||
*Often abbreviated '''RCC'''. | |||
*[[AKA]] ''hypernephroma''.<ref>URL:[http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001544/ http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001544/]. Accessed on: 14 July 2011.</ref> | |||
*RCC represents approx. 90% of malignancies in kidneys of adults.<ref name=Ref_WMSP289>{{Ref WMSP|289}}</ref> | |||
===Origin=== | |||
*Proximal renal tubule. | |||
===Clinical=== | |||
* | *Classically described as a triad:<ref name=schmid>{{cite journal |author=Schmid HP, Szabo J |title=[Renal cell carcinoma--a current review] |language=German |journal=Praxis (Bern 1994) |volume=86 |issue=20 |pages=837?3 |year=1997 |month=May |pmid=9312811 |doi= |url=}}</ref> | ||
* | **Hematuria (most common symptom). | ||
**Abdominal mass. | |||
**Flank pain. | |||
*Frequently picked-up on imaging (incidentaloma) ~ 1/3 of cases. | |||
=== | ===Risk factors=== | ||
* | *[[Smoking]] - most important.<ref name=Ref_WMSP289>{{Ref WMSP|289}}</ref> | ||
* | *Chemical exposures (arsenic, asbestos, cadmium, organic solvents, pesticides, fungal toxins).<ref name=Ref_WMSP289>{{Ref WMSP|289}}</ref> | ||
* | *Chronic renal failure. | ||
**[[Acquired cystic renal disease]]. | |||
*Male>female (~2:1). | |||
*Hereditary - familial syndromes (see [[Hereditary RCC]]). | |||
*[[Obesity]].<ref name=pmid8770461>{{Cite journal | last1 = Chow | first1 = WH. | last2 = McLaughlin | first2 = JK. | last3 = Mandel | first3 = JS. | last4 = Wacholder | first4 = S. | last5 = Niwa | first5 = S. | last6 = Fraumeni | first6 = JF. | title = Obesity and risk of renal cell cancer. | journal = Cancer Epidemiol Biomarkers Prev | volume = 5 | issue = 1 | pages = 17-21 | month = Jan | year = 1996 | doi = | PMID = 8770461 }}</ref> | |||
=== | ===Subtypes of RCC=== | ||
RCC (renal cell carcinoma) comes in different subtypes:<ref name=Ref_PBoD1016>{{Ref PBoD|1016}}</ref> | |||
* | *Clear cell carcinoma (70-80% of RCC) -- abbrev. CCRCC. | ||
* | *Papillary renal cell carcinoma (10-15% of RCC) -- abbrev. PRCC. | ||
*Chromophobe renal carcinoma (5% of RCC) -- abbrev. ChRCC. | |||
*Collecting duct (Bellini duct) carcinoma (1% of RCC). | |||
* | |||
* | |||
Notes: | Notes: | ||
* | *Subtype is an independent predictor of mortality - but adds very little to multivariate models with staging information.<ref name=pmid19076149>{{Cite journal | last1 = Capitanio | first1 = U. | last2 = Cloutier | first2 = V. | last3 = Zini | first3 = L. | last4 = Isbarn | first4 = H. | last5 = Jeldres | first5 = C. | last6 = Shariat | first6 = SF. | last7 = Perrotte | first7 = P. | last8 = Antebi | first8 = E. | last9 = Patard | first9 = JJ. | title = A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. | journal = BJU Int | volume = 103 | issue = 11 | pages = 1496-500 | month = Jun | year = 2009 | doi = 10.1111/j.1464-410X.2008.08259.x | PMID = 19076149 }}</ref> | ||
*CCRCC tends to be worse than ChRCC and PRCC, probably due to higher incidence of mets.<ref name=pmid17886093>{{Cite journal | last1 = Delahunt | first1 = B. | last2 = Bethwaite | first2 = PB. | last3 = Nacey | first3 = JN. | title = Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. | journal = Pathology | volume = 39 | issue = 5 | pages = 459-65 | month = Oct | year = 2007 | doi = 10.1080/00313020701570061 | PMID = 17886093 }}</ref> | |||
*The exam answer (worst to best): clear cell RCC, papillary RCC, chromophobe RCC. | |||
===IHC - is it RCC?=== | |||
*RCC Ma (+), CD10 (+) -- specific for RCC<ref>{{cite journal |author=Zhou M, Roma A, Magi-Galluzzi C |title=The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms |journal=Clin. Lab. Med. |volume=25 |issue=2 |pages=247?7 |year=2005 |month=June |pmid=15848735 |doi=10.1016/j.cll.2005.01.004 |url=}}</ref> | |||
===IHC=== | ===IHC - differentiation of types=== | ||
*CK7+ | *Clear cell RCC vs. papillary RCC: | ||
** CK7 (-ve CCRCC), AMACR (+ve in PRCC).<ref name=pmid15848735>{{cite journal |author=Zhou M, Roma A, Magi-Galluzzi C |title=The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms |journal=Clin. Lab. Med. |volume=25 |issue=2 |pages=247?7 |year=2005 |month=June |pmid=15848735 |doi=10.1016/j.cll.2005.01.004 |url=}}</ref> | |||
*Papillary RCC type 1 vs. papillary RCC type 2: | |||
** E-cadherin +ve in PRCC type 2.<ref name=pmid14657952>{{cite journal |author=Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R |title=Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases |journal=Mod. Pathol. |volume=17 |issue=2 |pages=180? |year=2004 |month=February |pmid=14657952 |doi=10.1038/modpathol.3800032 |url=}}</ref> | |||
**[[EMA]] (MUC1) +ve in PRCC type 1.<ref name=pmid14657952/> | |||
*ChRCC vs. oncocytoma (ONC): | |||
* | ** CK7 (ChRCC +ve membrane), CK20, CD15.<ref name=pmid15848735/> | ||
** | ** CK7 -- ChRCC 86% +ve vs. ONC 0% +ve.<ref name=pmid17683191>{{cite journal |author=Liu L, Qian J, Singh H, Meiers I, Zhou X, Bostwick DG |title=Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis |journal=Arch. Pathol. Lab. Med. |volume=131 |issue=8 |pages=1290? |year=2007 |month=August |pmid=17683191 |doi= |url=http://journals.allenpress.com/jrnlserv/?request=get-abstract&issn=0003-9985&volume=131&page=1290 }}</ref> | ||
* | ** CD15 -- ChRCC 11% +ve vs. ONC 57% +ve.<ref name=pmid15500648>{{cite journal |author=Pan CC, Chen PC, Ho DM |title=The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases |journal=Histopathology |volume=45 |issue=5 |pages=452? |year=2004 |month=November |pmid=15500648 |doi=10.1111/j.1365-2559.2004.01962.x |url=}}</ref> | ||
** | ** Hale's colloidal iron +ve in ChRCC, usually neg. in ONC.<ref name=pmid18603673>{{cite journal |author=Geramizadeh B, Ravanshad M, Rahsaz M |title=Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma |journal=Indian J Pathol Microbiol |volume=51 |issue=2 |pages=167?1 |year=2008 |pmid=18603673 |doi= |url=http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2008;volume=51;issue=2;spage=167;epage=171;aulast=Geramizadeh }}</ref> | ||
**ChRCC | ** PAX2 -- ChRCC (1/11) +ve vs. ONC (20/23) +ve.<ref name=pmid17210525>{{cite journal |author=Memeo L, Jhang J, Assaad AM, ''et al.'' |title=Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma |journal=Am. J. Clin. Pathol. |volume=127 |issue=2 |pages=225–9 |year=2007 |month=February |pmid=17210525 |doi=10.1309/9KWEA4W9Y94D1AEE |url=http://ajcp.ascpjournals.org/cgi/pmidlookup?view=long&pmid=17210525}}</ref> | ||
**Kidney-specific cadherin (Ksp-cadherin) -- ChRCC 97% +ve (distinctive membrane pattern) vs. ONC only 3% +ve.<ref name=pmid15712178>{{cite journal |author=Mazal PR, Exner M, Haitel A, ''et al.'' |title=Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma |journal=Hum. Pathol. |volume=36 |issue=1 |pages=22–8 |year=2005 |month=January |pmid=15712178 |doi=10.1016/j.humpath.2004.09.011 |url=}}</ref> | |||
== | *ChRCC & renal oncocytoma vs. others: | ||
=== | ** CD117 (ckit) +ve (100% membrane, ~75% cytoplasmic).<ref>{{cite journal |author=Krueger S, Sotlar K, Kausch I, Horny HP |title=Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma |journal=Oncology |volume=68 |issue=2-3 |pages=269-75 |year=2005 |pmid=16015044 |doi=10.1159/000086783 |url=}}</ref> | ||
* | *Clear cell RCC vs. chromophobe RCC: | ||
**Hale's colloidal iron (+ve in ChRCC).<ref name=pmid18603673/> | |||
**CK7 (cell membrane +ve in ChRCC). | |||
=== | Notes: | ||
*One paper<ref>{{cite journal |author=Martignoni G, Brunelli M, Gobbo S, ''et al'' |title=Role of molecular markers in diagnosis and prognosis of renal cell carcinoma |journal=Anal. Quant. Cytol. Histol. |volume=29 |issue=1 |pages=41? |year=2007 |month=February |pmid=17375873 |doi= |url=}}</ref> describes CD10, parvalbumin, AMACR, CK7 and S100A1 as being useful. | |||
* | *Another paper I came across:<ref>{{cite journal |author=Avery AK, Beckstead J, Renshaw AA, Corless CL |title=Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms |journal=Am. J. Surg. Pathol. |volume=24 |issue=2 |pages=203?0 |year=2000 |month=February |pmid=10680888 |doi= |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0147-5185&volume=24&issue=2&spage=203}}</ref> | ||
*c-kit (CD117) not useful for differentiating ONC and ChRCC.<ref name=pmid17210525>{{cite journal |author=Memeo L, Jhang J, Assaad AM, ''et al.'' |title=Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma |journal=Am. J. Clin. Pathol. |volume=127 |issue=2 |pages=225–9 |year=2007 |month=February |pmid=17210525 |doi=10.1309/9KWEA4W9Y94D1AEE |url=http://ajcp.ascpjournals.org/cgi/pmidlookup?view=long&pmid=17210525}}</ref> | |||
*E-cadherin ''not'' useful for differentiating ChRCC and ONC.<ref name=pmid12613443>{{cite journal |author=Kim MK, Kim S |title=Immunohistochemical profile of common epithelial neoplasms arising in the kidney |journal=Appl. Immunohistochem. Mol. Morphol. |volume=10 |issue=4 |pages=332–8 |year=2002 |month=December |pmid=12613443 |doi= |url=}}</ref> | |||
* | |||
===RCC vs. Urothelial cell carcinoma=== | |||
==Urothelial cell carcinoma== | |||
{{main|Urothelium}} | {{main|Urothelium}} | ||
*Clinically/radiologically, it may not be possible to differentiate renal pelvis UCC and RCC if the tumour is large. | *Clinically/radiologically, it may not be possible to differentiate renal pelvis UCC and RCC if the tumour is large. | ||
*Pathologically, this is not very difficult. | *Pathologically, this is not very difficult. | ||
*On gross specimens, it is almost always obvious what one is dealing with: | *On gross specimens, it is almost always obvious what one is dealing with: | ||
**UCC = ''nephroureterectomy''. | **[[UCC]] = ''[[nephroureterectomy]]''. | ||
**RCC = ''nephrectomy'' or ''radical nephrectomy''. | **[[RCC]] = ''[[partial nephrectomy]]'', ''nephrectomy'' or ''[[radical nephrectomy]]''. | ||
= | ===Renal cell carcinoma with sarcomatoid differentiation=== | ||
*[[AKA]] ''sarcomatoid renal cell carcinoma''. | |||
{{Main|Renal cell carcinoma with sarcomatoid differentiation}} | |||
== | ===Renal cell carcinoma with rhabdoid morphology=== | ||
*[[AKA]] ''renal cell carcinoma with rhabdoid change''. | |||
* | {{Main|Renal cell carcinoma with rhabdoid morphology}} | ||
=== | ==Hereditary renal cell carcinoma== | ||
{{Main|Hereditary renal cell carcinoma}} | |||
==Renal cell carcinoma grading== | |||
{{Main|Renal cell carcinoma grading}} | |||
=== | ==Renal cell carcinoma staging== | ||
{{Main|Kidney cancer staging}} | |||
===Renal sinus invasion=== | |||
{{Main|Kidney cancer staging}} | |||
==Clear cell renal cell carcinoma== | |||
{{Main|Clear cell renal cell carcinoma}} | |||
== | ==Multilocular cystic renal cell carcinoma== | ||
{{Main|Multilocular cystic renal cell carcinoma}} | |||
=== | ==Papillary renal cell carcinoma== | ||
{{Main|Papillary renal cell carcinoma}} | |||
=== | ==Chromophobe renal cell carcinoma== | ||
{{Main|Chromophobe renal cell carcinoma}} | |||
== | ==Clear cell papillary renal cell tumour== | ||
In the past, it was known as ''clear cell papillary renal cell carcinoma''. | |||
{{Main|Clear cell papillary renal cell tumour}} | |||
=== | ==Unclassified renal cell carcinoma== | ||
*Abbreviated ''URCC''. | |||
* | {{Main|Unclassified renal cell carcinoma}} | ||
=Renal translocation carcinomas= | |||
==Renal tumour with Xp11.2 translocation== | |||
{{Main|Renal tumour with Xp11.2 translocation}} | |||
== | ==Renal tumour with t(6;11) translocation== | ||
*[[AKA]] ''t(6;11) renal cell carcinoma''. | |||
* | {{main|Renal tumour with t(6;11) translocation}} | ||
=== | =Benign tumours= | ||
* | ==Papillary adenoma of the kidney== | ||
*[[AKA]] ''renal papillary adenoma''. | |||
{{Main|Papillary adenoma of the kidney}} | |||
==Renal oncocytoma== | |||
{{Main|Renal oncocytoma}} | |||
== | ==Angiomyolipoma== | ||
* | *Abbreviated ''AML''. | ||
{{Main|Angiomyolipoma}} | |||
=Mimics= | |||
==Xanthogranulomatous pyelonephritis== | |||
* | *Abbreviated ''XGP''. | ||
{{Main|Xanthogranulomatous pyelonephritis}} | |||
==Malakoplakia== | ==Malakoplakia== | ||
| Line 337: | Line 388: | ||
=Rare stuffs= | =Rare stuffs= | ||
== | ==Juxtaglomerular cell tumour== | ||
=== | *[[AKA]] juxtaglomerular tumour, reninoma.<ref name=pmid18192852>{{Cite journal | last1 = Wong | first1 = L. | last2 = Hsu | first2 = TH. | last3 = Perlroth | first3 = MG. | last4 = Hofmann | first4 = LV. | last5 = Haynes | first5 = CM. | last6 = Katznelson | first6 = L. | title = Reninoma: case report and literature review. | journal = J Hypertens | volume = 26 | issue = 2 | pages = 368-73 | month = Feb | year = 2008 | doi = 10.1097/HJH.0b013e3282f283f3 | PMID = 18192852 }}</ref> | ||
{{Main|Juxtaglomerular cell tumour}} | |||
=== | ==Renomedullary interstitial cell tumour== | ||
*[[AKA]] ''medullary fibroma''.<ref name=pmid11054036 >{{Cite journal | last1 = Bircan | first1 = S. | last2 = Orhan | first2 = D. | last3 = Tulunay | first3 = O. | last4 = Safak | first4 = M. | title = Renomedullary interstitial cell tumor. | journal = Urol Int | volume = 65 | issue = 3 | pages = 163-6 | month = | year = 2000 | doi = | PMID = 11054036 }}</ref> | |||
{{Main|Renomedullary interstitial cell tumour}} | |||
== | ==Metanephric adenoma== | ||
* | *Should '''not''' be confused ''[[mesonephric adenoma]]'', another term for ''nephrogenic adenoma''. | ||
**Memory device: me'''t'''anephric adenoma is a '''t'''umour. | |||
{{Main|Metanephric adenoma}} | |||
=== | ==Renal epithelial and stromal tumour== | ||
:Abbreviated ''REST''. | |||
The lumping term for both:<ref name=pmid17414095>{{Cite journal | last1 = Turbiner | first1 = J. | last2 = Amin | first2 = MB. | last3 = Humphrey | first3 = PA. | last4 = Srigley | first4 = JR. | last5 = De Leval | first5 = L. | last6 = Radhakrishnan | first6 = A. | last7 = Oliva | first7 = E. | title = Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. | journal = Am J Surg Pathol | volume = 31 | issue = 4 | pages = 489-500 | month = Apr | year = 2007 | doi = 10.1097/PAS.0b013e31802bdd56 | PMID = 17414095 }}</ref> | |||
#[[Mixed epithelial and stromal tumour]]. | |||
#[[Cystic nephroma]]. | |||
== | ==Mixed epithelial and stromal tumour== | ||
*Abbreviated ''MEST''. | |||
* | {{Main|Mixed epithelial and stromal tumour of the kidney}} | ||
=== | ==Cystic nephroma== | ||
{{Main|Cystic nephroma}} | |||
==Renal mucinous tubular and spindle cell carcinoma== | |||
* | *[[AKA]] ''renal mucinous tubular spindle cell carcinoma''. | ||
* | *[[AKA]] ''mucinous tubular and spindle cell carcinoma of the kidney''.<ref name=pmid16258504>{{Cite journal | last1 = Brandal | first1 = P. | last2 = Lie | first2 = AK. | last3 = Bassarova | first3 = A. | last4 = Svindland | first4 = A. | last5 = Risberg | first5 = B. | last6 = Danielsen | first6 = H. | last7 = Heim | first7 = S. | title = Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas. | journal = Mod Pathol | volume = 19 | issue = 2 | pages = 186-94 | month = Feb | year = 2006 | doi = 10.1038/modpathol.3800499 | PMID = 16258504 }}</ref> | ||
{{Main|Renal mucinous tubular and spindle cell carcinoma}} | |||
==Collecting duct carcinoma== | |||
{{Main|Collecting duct carcinoma}} | |||
== | ==Renal medullary carcinoma== | ||
{{Main|Renal medullary carcinoma}} | |||
=== | ==Tubulocystic carcinoma of the kidney== | ||
{{Main|Tubulocystic carcinoma of the kidney}} | |||
==Acquired cystic disease-associated renal cell carcinoma== | |||
{{Main|Acquired cystic disease-associated renal cell carcinoma}} | |||
== | ==Kidney metastasis== | ||
*[[AKA]] ''renal metastasis'', ''metastatic kidney disease''. | |||
* | {{Main|Kidney metastasis}} | ||
= | =Pediatric= | ||
{{Main|Pediatric kidney tumours}} | |||
The most common is [[nephroblastoma]] (Wilms tumour). | |||
Others include: | |||
* | *[[Metanephric stromal tumour]]. | ||
* | *[[Metanephric adenofibroma]] | ||
*[[Metanephric adenoma]]. | |||
*[[Clear cell sarcoma of the kidney]]. | |||
=See also= | |||
*[[Urinary bladder]]. | *[[Urinary bladder]]. | ||
*[[Medical kidney]]. | *[[Medical kidney]]. | ||
*[[Malakoplakia]] - yellow lesion on gross; may mimic RCC. | |||
=References= | |||
{{reflist|2}} | {{reflist|2}} | ||
=External links= | |||
*[http://www.uscap.org/site~/99th/pdf/companion13h03.pdf Renal tumours with eosinophilic cytoplasm (uscap.org)]. | |||
[[Category: Genitourinary pathology]] | [[Category: Genitourinary pathology]] | ||